If your current formulation uses cyanocobalamin and you're not seeing expected results, switching to a methylcobalamin-based formula is reasonable
Perineuronal nets decrease membrane capacitance of peritumoral fast spiking interneurons in a model of epilepsy
Key Points With the FDA approval of GLP-1 agonists in pill form, the healthcare industry is looking to build on last year's momentum
Acta 1249 , 2936 (1995)
Specifically, GLP-1s appear to dampen activity in reward-related regions like the nucleus accumbens, which plays a key role in cravings, dopamine release, and conditioned food responses
The 3,000 mg dose sits at the upper end of the clinical range (1,000-4,500 mg/day), providing the maximum fatty acid transport capacity for training sessions